HOME >> BIOLOGY >> NEWS
Promising research: From employment issues to virology

as molecular data is required to produce the correct kinships between the species. The researchers are to close the gaps in our knowledge caused by ambiguous interpretations of data, a lack of examinations and insufficient descriptions.
(Coordinator: Professor Dr. Johann-Wolfgang Wgele, University of Bochum)

Humanities and Social Sciences

Many companies offer older employees the possibility of early retirement, enabling younger and supposedly more productive employees to move up. The combination of an extended life expectancy and constantly decreasing employment is one reason for the crisis in Germany's social security systems. The researchers involved in the new Priority Programme "Age-Differentiated Work Systems" want to develop strategies on how to deploy employees in a company according to their age so that they remain employed for a longer period of time. So-called life span models are meant to give concrete information on how to optimise work sys-tems and what measures can be used to provide adequate working conditions for different age groups.
(Coordinator: Professor Dr. Ekkehart Frieling, University of Kassel)

In the wake of European unification, the question of Europe's cultural identity is being dis-cussed intensively. In the new Priority Programme "Integration and De-integration of Cul-tures in the European Middle Ages", researchers are questioning the theory of Europe's uniform Christian culture, which was previously accepted in research. Even before the Middle Ages, Latin-Christian Europe experienced constant interaction with the Greek-Orthodox, Jew-ish and Islamic cultures. However, this confrontation did not lead to a mutual delimitation, but rather to the adaptation and exchange of different religious beliefs. The participating histori-ans, Islamic researchers, economists and theologians hope to achieve a better understanding of the historical development of Europe by studying transcultural relat
'"/>

Contact: Dr. Cornelia Pretzer
cornelia.pretzer@dfg.de
49-228-885-2376
Deutsche Forschungsgemeinschaft
21-May-2004


Page: 1 2 3 4 5 6

Related biology news :

1. Promising hospital anti-infection strategy probably wont work, study shows
2. Promising new tool shows how dividing cells finish what they start
3. Promising biomarker for melanoma is identified
4. Promising multi-strain HIV vaccine candidate emerges
5. Promising new therapies for deadly form of leukemia
6. Dr. Robert C. Gallo to Collaborate with Visiting Israeli Scientist on Promising HIV Vaccine Research at Marylands Institute of Human Virology
7. SFU Spin-Off Company To Research Promising Antibacterial Agents
8. SFU Molecular Biologist Pursues Promising New Way To Fight Disease
9. UNC-CH Researchers Develop Promising Heart Research Tool
10. Duke Researchers Call Gene Therapy A Promising Strategy For Sickle Cell Anemia
11. Promising Fatty Acid Research Leads To MS Clinical Trial

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Promising research From employment issues virology

(Date:6/30/2015)... 30, 2015 Genisphere announced ... to help further develop Genisphere,s therapeutics capabilities and portfolio. ... having spent much of the last 25 years in ... Bioscience, and Johnson & Johnson. Tom started his career ... Biotech Corporate Finance. He graduated from Dartmouth College with ...
(Date:6/26/2015)... 26, 2015 ATL Technology, LLC, a top provider ... in single use solutions, headquartered in Springville, Utah ... California corporation with locations in ... Jose, Costa Rica ). This acquisition will ... with ATL Technology,s existing facility in Costa ...
(Date:6/25/2015)... , June 25, 2015  Imagine a tool specifically ... a healthier, happier life. That,s exactly what USANA,s ... do. The cutting-edge, portable health program provides a personalized ... to help improve your lifestyle and nutrition. ... and gala Wednesday night, USANA,s THA was honored with ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2
(Date:7/2/2015)... , ... July 02, 2015 , ... ... and manufacturing of surgical instruments in Orthopedics, announced today the acquisition of ... the world's largest provider of surgical instruments to the Spine Industry. The acquisition ...
(Date:7/1/2015)... , July 1, 2015   Decision Resources ... cited advantages of Otezla are its oral administration, ... as reported by surveyed rheumatologists. Otezla was the ... the treatment of active psoriatic arthritis in ... standard of care includes conventional oral treatments including ...
(Date:7/1/2015)... ALTO, Calif. , July 1, 2015 /PRNewswire/ ... focused on the development of groundbreaking drugs to ... (ALS), announced today that Robert G. Miller ... Center at Sutter Health,s California Pacific Medical Center ... The ALS Association for $1.5 million to help ...
(Date:7/1/2015)... ... July 01, 2015 , ... A newly launched business ... to lower the barriers to innovation in life sciences R&D. The Pistoia Alliance President’s ... cash prizes of US$15,000 and a period of expert mentorship from a senior industry ...
Breaking Biology Technology:In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3
Cached News: